ANTIANDROGEN MONOTHERAPY MARKET ANALYSIS
Global Antiandrogen Monotherapy Market - Regional Insights
On the basis of region, the antiandrogen monotherapy market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. According to the American Society of Clinical Oncology (ASCO), around 191,930 new cases of prostate cancer is estimated to be diagnosed in the U.S., in 2020. North America holds a dominant position in the global antiandrogen monotherapy market due to increasing prevalence of prostate cancer in the region.
Europe is also showcasing high growth in antiandrogen monotherapy market due to increasing prevalence of prostate cancer. According to the Cancer Research UK, around 48,487 cases of prostate cancer were reported in the U.K. during 2015-2017.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
